Novartis Oncology - Company Review
Novartis Oncology - Company ReviewSummary
Novartis Oncology (Novartis) is a provider of patient care and research programs. The center offers clinical trials, research and development; lifecycle management and patient assistance services. It offers patient assistance and treatment service for acromegaly, ALK and non-small cell lung cancer; bone metastasis, breast cancer, chronic myeloid leukemia, Cushing’s disease, gastrointestinal stromal tumors, iron overload, metastatic melanoma, multiple myeloma and others. The center’s research and development services comprise target discovery and drug design; preclinical safety and efficacy; proof of concept and phase studies; clinical development, and registration and post launch services. It caters to patients and physicians in Norway. Novartis is headquartered in Oslo, Norway.
This comprehensive company report of Novartis Oncology provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.